Gian Luca Grazi

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 72 Citations 19,758 296 World Ranking 16312 National Ranking 622

Overview

What are the main themes of his work throughout his whole career to date

As part of his studies on Internal medicine, Gian Luca Grazi frequently links adjacent subjects like Fibrosis. His study connects Internal medicine and Fibrosis. His work often combines Cancer and Colorectal cancer studies. He brings together Virus and Asymptomatic to produce work in his papers. Asymptomatic and Virus are two areas of study in which Gian Luca Grazi engages in interdisciplinary research. As part of his studies on Immunology, Gian Luca Grazi often connects relevant subjects like Hepatitis C virus. Hepatitis C virus is frequently linked to Immunology in his study. By researching both Hepatitis and Liver transplantation, he produces research that crosses academic boundaries. In his research, Gian Luca Grazi performs multidisciplinary study on Liver transplantation and Hepatitis C.

Gian Luca Grazi most often published in these fields:

Internal medicine (80.00%)
Cancer (60.00%)
Virus (60.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori.
Lancet Oncology (2009)

1844 Citations

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)

1341 Citations

Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

Laura Gramantieri;Manuela Ferracin;Francesca Fornari;Angelo Veronese.
Cancer Research (2007)

1018 Citations

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

Francesca Fornari;Laura Gramantieri;Manuela Ferracin;A Veronese.
Oncogene (2008)

771 Citations

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)

562 Citations

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

Francesca Fornari;Laura Gramantieri;Catia Giovannini;Angelo Veronese.
Cancer Research (2009)

476 Citations

MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells

Francesca Fornari;Maddalena Milazzo;Pasquale Chieco;Massimo Negrini.
Cancer Research (2010)

465 Citations

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Giorgio Ercolani;Gian Luca Grazi;Matteo Ravaioli;Massimo Del Gaudio.
Annals of Surgery (2003)

443 Citations

MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality

Laura Gramantieri;Francesca Fornari;Manuela Ferracin;Angelo Veronese.
Clinical Cancer Research (2009)

394 Citations

Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value

Gian Luca Grazi;Giorgio Ercolani;Filippo Pierangeli;Massimo Del Gaudio.
Annals of Surgery (2001)

387 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Gian Luca Grazi